SCHEMBL5350823

SCHEMBL5350823

COc1cccc(CC(=O)O)c1NC(=O)Nc1ccccc1C

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTGS2 P35354 3/20 0.53
▸ MEN1 O00255 3/20 0.52
▸ KMT2A Q03164 3/20 0.52
▸ GAA P10253 1/20 0.52
▸ PKM P14618 1/20 0.51
▸ MAPT P10636 3/20 0.49
▸ POLB P06746 1/20 0.49
▸ LPAR1 Q92633 1/20 0.49
▸ ITGB3 P05106 2/20 0.49
▸ ITGAV P06756 2/20 0.49
▸ ITGB1 P05556 2/20 0.49
▸ ITGA5 P08648 1/20 0.49
▸ GFER P55789 1/20 0.47
▸ DDX3X O00571 1/20 0.47
▸ SMN1; SMN2 Q16637 1/20 0.46
▸ ITGA4 P13612 1/20 0.46
▸ IDO1 P14902 1/20 0.45
▸ NPC1 O15118 2/20 0.45
▸ RAB9A P51151 2/20 0.45
▸ ATM Q13315 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6543559 0.87 KMT2A (0.52) MEN1KMT2APKMMAPTLPAR1
SCHEMBL7079595 0.85 HIF1A (0.60) MEN1KMT2AMAPTPOLBSMN1; SMN2
SCHEMBL6542890 0.83 MEN1 (0.46) MEN1KMT2AGAAPKMMAPT
SCHEMBL5991743 0.81 PTGS2 (0.63) PTGS2MEN1KMT2AGAAMAPT
SCHEMBL6257325 0.78 ITGA4 (0.44) MEN1KMT2AGAAPKMMAPT
SCHEMBL4683165 0.77 ITGA4 (0.67) MEN1KMT2AGAAMAPTPOLB
SCHEMBL20540167 0.76 KMT2A (0.61) MEN1KMT2AGAAPKMMAPT
SCHEMBL5273139 0.74 NR3C2 (0.45) MEN1KMT2AMAPTPOLBSMN1; SMN2
SCHEMBL7798245 0.74 HSD17B10 (0.53) PTGS2MEN1KMT2AMAPTPOLB
SCHEMBL5157330 0.74 MAPT (0.56) MEN1KMT2AGAAMAPTPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7211586-B2 Substituted tetrahydroisoquinolines AVENTIS PHARMA LIMITED (GB) 2007-05-01 — — US disclosed
EP-1392306-A1 SUBSTITUTED TETRAHYDROISOQUINOLINES FOR USE IN THE TREATMENT OF INFLAMMATORY DISEASES Aventis Pharma Limited (GB) 2004-03-03 — — EP disclosed
WO-2002098426-A1 SUBSTITUTED TETRAHYDROISOQUINOLINES FOR USE IN THE TREATMENT OF INFLAMMATORY DISEASES AVENTIS PHARMA LIMTIED (GB) 2002-12-12 — — WO disclosed
Send feedback